| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.088 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.093 | 0.09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |